Ignite Creation Date:
2025-12-24 @ 6:29 PM
Ignite Modification Date:
2025-12-28 @ 6:16 PM
Study NCT ID:
NCT00785668
Status:
COMPLETED
Last Update Posted:
2008-11-05
First Post:
2008-11-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1 Safety and Pharmacokinetics Study of AER 001 Administered as a Dry Powder in Asthmatic Subjects
Sponsor:
Aerovance, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
QGUY/2007/AER 001/-04
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
Aerovance Inc.